London Confirms More Mpox Cases

UK Health Security Agency (UKHSA) announced today London had reported 11 new mpox cases within the past few weeks.

Most of these cases were in unvaccinated individuals. However, three were in those who had only received one dose of Bavarian Nordic's JYNNEOS® (MVA-BN) vaccine.

In response to London's mpox outbreak, the UKHSA vaccinations would be offer in London to qualifying men beyond July 2023.

After the end of July, people who regularly travel to London or abroad to have sex and are eligible for the JYNNEOS vaccine are empowered to schedule a London-based appointment using the vaccine finder.

Dr. Claire Dewsnap, President of the British Association for Sexual Health and HIV, commented in a related press release, "We strongly encourage all those eligible to book an appointment to receive a mpox vaccination, especially given the worrying recent spike in cases."

"One dose of the vaccine protects against the virus, and the second dose can further prevent severe symptoms and transmission."

"This is particularly important as we move into the summer months, during which festivals and events are more common, increasing the likelihood for people to have multiple sexual partners."

As of June 16, 2023, 21 mpox cases have been reported in the UK.

Other mpox outbreaks are posted by Vax-Before-Travel.